| Pharmaceutical Information |
| Drug Name |
Mafenide |
| Drug ID |
BADD_D01337 |
| Description |
Mafenide is a sulfonamide-type antimicrobial agent used to treat severe burns. It acts by reducing the bacterial population present in the burn tissue and promotes healing of deep burns. |
| Indications and Usage |
Indicated for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.[label] |
| Marketing Status |
approved; vet_approved |
| ATC Code |
D06BA03 |
| DrugBank ID |
DB06795
|
| KEGG ID |
D02351
|
| MeSH ID |
D008272
|
| PubChem ID |
3998
|
| TTD Drug ID |
D0K1QD
|
| NDC Product Code |
Not Available |
| UNII |
58447S8P4L
|
| Synonyms |
Mafenide | Maphenid | Mafenide Acetate | Sulfamylon | Marfanil | Napaltan | 4-Homosulfanilamide | 4 Homosulfanilamide | Sulfabenzamine | Bensulfamide | Mafylon |
|
| Chemical Information |
| Molecular Formula |
C7H10N2O2S |
| CAS Registry Number |
138-39-6 |
| SMILES |
C1=CC(=CC=C1CN)S(=O)(=O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
